Description:
A drug used under the brand name Myleran to treat chronic myelogenous leukemia (CML) and with other drugs under the brand name Busulfex to prepare patients with CML for a donor stem cell transplant. It is also being studied in the treatment of other types of cancer. Busulfan damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent.
